CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
54.37
+1.63 (3.09%)
Sep 5, 2025, 3:20 PM - Market open
CRISPR Therapeutics AG Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$72.27
Upside
+32.92%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $65 → $80 | Strong Buy | Maintains | $65 → $80 | +47.14% | Aug 7, 2025 |
Barclays | Barclays | Hold Maintains $42 → $56 | Hold | Maintains | $42 → $56 | +3.00% | Aug 6, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $82 | Strong Buy | Maintains | $82 | +50.82% | Aug 5, 2025 |
RBC Capital | RBC Capital | Hold Maintains $38 → $42 | Hold | Maintains | $38 → $42 | -22.75% | Aug 5, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $79 → $78 | Strong Buy | Maintains | $79 → $78 | +43.46% | Jul 22, 2025 |
Needham | Needham | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +48.98% | Jul 8, 2025 |
Clear Street | Clear Street | Strong Buy → Hold Downgrades $45 | Strong Buy → Hold | Downgrades | $45 | -17.23% | Jun 27, 2025 |
Piper Sandler | Piper Sandler | Buy Reiterates $105 | Buy | Reiterates | $105 | +93.12% | Jun 27, 2025 |
JMP Securities | JMP Securities | Buy Reiterates $86 | Buy | Reiterates | $86 | +58.18% | Jun 27, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +19.55% | Jun 27, 2025 |
Needham | Needham | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +48.98% | Jun 26, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $82 | Strong Buy | Maintains | $82 | +50.82% | Jun 26, 2025 |
JMP Securities | JMP Securities | Buy Reiterates $86 | Buy | Reiterates | $86 | +58.18% | May 21, 2025 |
Needham | Needham | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +48.98% | May 20, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +19.55% | May 20, 2025 |
Barclays | Barclays | Hold Maintains $56 → $42 | Hold | Maintains | $56 → $42 | -22.75% | May 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.